IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 221 filers reported holding IVERIC BIO INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,532,790 | -44.4% | 63,000 | -51.0% | 0.03% | -30.2% |
Q4 2022 | $2,755,467 | -93.4% | 128,700 | -94.5% | 0.04% | -92.5% |
Q3 2022 | $41,724,000 | +636.5% | 2,325,600 | +294.9% | 0.58% | +638.5% |
Q2 2022 | $5,665,000 | -19.1% | 588,905 | +41.5% | 0.08% | -7.1% |
Q1 2022 | $7,005,000 | +10.8% | 416,200 | +6.9% | 0.08% | +16.7% |
Q3 2021 | $6,325,000 | – | 389,415 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |